24 results
424B5
TRML
Tourmaline Bio Inc
26 Jan 24
Prospectus supplement for primary offering
4:08pm
) on the net gain derived from the disposition, which may be offset by certain U.S. source capital losses of the non-U.S. holder, if any (even though
424B5
TRML
Tourmaline Bio Inc
24 Jan 24
Prospectus supplement for primary offering
9:20pm
between the United States and such holder’s country of residence) on the net gain derived from the disposition, which may be offset by certain U.S
8-K
EX-99.2
h4q nkgdm
24 Jan 24
Results of Operations and Financial Condition
5:10pm
S-4
EX-10.1
dg0s8o9j46o a44s12
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
10-K
npneb 8cfo
17 Mar 22
Annual report
4:31pm
10-Q
18hrxmkho2hjhn n2
14 Jun 21
Quarterly report
4:21pm
424B4
4enivptl b45vhek
10 May 21
Prospectus supplement with pricing info
4:20pm